Efaroxan
Alternative Names: RX 821037Latest Information Update: 22 Jan 2001
At a glance
- Originator Pierre Fabre
- Class Antihyperglycaemics; Benzofurans; Imidazoles; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 22 Jan 2001 Discontinued-II for Diabetes mellitus in United Kingdom (Unknown route)
- 07 Jul 1999 No-Development-Reported for Diabetes mellitus in United Kingdom (Unknown route)
- 12 Jul 1995 Phase-II clinical trials for Diabetes mellitus in United Kingdom (Unknown route)